CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study. - Frank MJ; Baird JH; Kramer AM; Srinagesh HK; Patel S; Brown AK; Oak JS; Younes SF; Natkunam Y; Hamilton MP; Su YJ; Agarwal N; et al. (Lancet (London, England), 2024)